A steady decline in mortality rates since the 19th century has brought about a long-term rise in life expectancy for both men and women, but progress is uneven and, as recent history tells us, uncertain.
This white paper investigates the emergence of excess mortality and new-onset disease resulting in insurance underwriting significance beyond 30 days from the time of infection.
With interest in wellness rising rapidly across the insurance industry, a research collaboration between RGA and the University of Leicester seeks to provide critical insights to enhance underwriting and pricing for wellness products, as well as to inform consumers on ways to improve their health and longevity.
Forecasting long-term mortality improvement trends for insurance
A coalition of insurance industry and healthcare leaders have formed a non-profit organization to help global insurers screen, test, and triage members to combat the baffling rise in excess mortality.
This report examines the impact of mental illness on U.S. population mortality and longevity. It also explores the impact of the COVID-19 pandemic on mental illness.
Decades of research have demonstrated how individual health conditions and behaviors impact morbidity and mortality. When underwriting life and health insurance, however, determining how multiple wellness and lifestyle rating factors and comorbidities interact and affect one another remains challenging.
Why “secondary” excess mortality and mortality assumption uncertainty is in fact likely to continue for several more years.
A Study of TrueRisk Life as a Mortality Predictor in the Contemporary United States Credit Active Population
In 2012, Reinsurance Group of America (RGA) completed its initial assessment of TrueRisk Life in the United States. In a new study, RGA looks back and finds that credit data continues to be a strong predictor of mortality, even over the extended time period.
The global pandemic’s toll on cancer diagnoses and what it may mean for the future of US life expectancy